Navigation Links
Vaccine yielded encouraging long-term survival rates in certain patients with NSCLC
Date:4/4/2012

CHICAGO Long-term follow-up of a phase II clinical trial showed encouraging survival in some patients with stage 3B/4 non-small cell lung cancer treated with belagenpumatucel-L, a therapeutic vaccine. The findings were presented here at the AACR Annual Meeting 2012, held March 31 - April 4.

"This is a novel immunotherapy that appears to show unusually long survival in some patients," said Lyudmila Bazhenova, M.D., associate clinical professor at the University of California-San Diego Moores Cancer Center in La Jolla, Calif.

These findings represent an updated long-term survival analysis on patients treated with belagenpumatucel-L, a cell-based allogeneic vaccine derived from four lung cancer cell lines. The open-label study included 75 patients with non-small cell lung cancer (NSCLC) two patients with stage 2 disease, 12 with stage 3A, 15 with stage 3B and 46 with stage 4. The researchers randomly assigned patients to three dose cohorts: 1.25, 2.5 or 5 107 cells/injection.

For all patients, median survival was 14.5 months, and the five-year survival rate was 20 percent. The 40 patients with stage 3B/4 cancer enrolled in the second and third dose cohorts had a median survival of 15.9 months and a one-year survival rate of 61 percent, a two-year survival rate of 41 percent and a five-year survival rate of 18 percent.

Patients with stage 3B/4 nonprogressive disease after chemotherapy had a median survival of 44.4 months; five-year survival was 50 percent, which is "unheard of for patients with NSCLC," Bazhenova said.

In contrast, patients who progressed after front-line chemotherapy had a median survival rate of 14.1 months and a 9.1 percent five-year survival rate.

Bazhenova said that although these results are intriguing, they must be confirmed in a phase III clinical trial, which is currently under way in eight countries.


'/>"/>
Contact: Jeremy Moore
Jeremy.Moore@aacr.org
215-446-7109
American Association for Cancer Research
Source:Eurekalert

Page: 1

Related medicine news :

1. Vaccine May Prevent TB in People With HIV
2. Vaccine Not Fail-Safe in Ongoing Mumps Outbreak
3. New strategy produces promising advance in cancer vaccines
4. Screens, Vaccine for HPV Less Beneficial in Older Women
5. New Technology Could Widen Reach of Vaccines
6. Texas-based consortium announces groundbreaking vaccine research program
7. The Coalition for Vaccine Safety Calls for Congressional Hearings on Federal Agencies Failure to Provide Adequate Safety Research
8. Possible vaccine for mesothelioma proven safe
9. Groundbreaking research to find vaccine for hepatitis C
10. Vaccine for Asbestos-Related Cancer Looks Safe
11. CDC Awards Abt Associates Additional Contracts to Evaluate Effectiveness of H1N1 Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/2/2020)... (PRWEB) , ... April 02, 2020 , ... LifeLearn ... VetFolio , today announced the launch of the veterinary CE course COVID-19: What ... indefinitely for VetFolio subscribers. , “When it comes to COVID-19, it’s important for practices ...
(Date:4/1/2020)... Va. (PRWEB) , ... April 02, 2020 , ... Medical ... 3:00 p.m. EDT, https://www.fdanews.com/mdchangemanagement , What change management method should one ... the method is often dependent on the type of change. Is it due to ...
(Date:4/1/2020)... ... April 01, 2020 , ... “Medical ... under California law,” says Keller Grover LLP attorney Eric A. Grover. “For ... breaches and the negligent release and disclosure of medical information can, under certain ...
(Date:3/28/2020)... (PRWEB) , ... March 27, 2020 , ... ... workers and the public from the spread of the coronavirus. Operating under the ... are pressing forward with infrastructure renewal and environmental protection projects in the downstate ...
(Date:3/27/2020)... ... March 27, 2020 , ... Justin ... NJ Top Docs. Dr. Kubeck has been approved every year consecutively since 2016. ... specializes in Spinal Surgery. , Dr. Kubeck’s medical education began at Thomas ...
Breaking Medicine News(10 mins):
(Date:4/2/2020)... HOUSTON (PRWEB) , ... April 02, 2020 , ... ... (PA) program freshman has won SignatureCare Emergency Center's 2020 Spring Semester Scholarship. ... and commitment to the medical and healthcare field, is aimed at helping the ...
(Date:4/1/2020)... ... April 01, 2020 , ... ... is continuing her partnership with the esteemed Haute Beauty network. , The Haute ... present Dr. Green as a leading Anti-Aging Expert. , Haute Beauty offers a ...
(Date:4/1/2020)... ... April 01, 2020 , ... ... reusable face shields. As large manufacturers nation-wide scramble to retool their machinery to ... masks or in extreme cases, using hand-sewn masks to protect employees from contracting ...
Breaking Medicine Technology: